Paper36925682
Hybrid cell constructs consisting of bioprinted cell-spheroids.
Kim W and 1 other. Bioeng Transl Med, 2023. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Hybrid cell constructs consisting of bioprinted cell-spheroids. Papers, record 36925682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36925682
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,880,266 | Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. | Am J Physiol Cell Physiol | 2002 | https://conductscience.org/library/papers/11880266 | PubMed |
| 2 | 26,756,674 | A liver-on-a-chip platform with bioprinted hepatic spheroids. | Biofabrication | 2016 | https://conductscience.org/library/papers/26756674 | PubMed |
| 3 | 31,402,593 | Fabrication Techniques for Vascular and Vascularized Tissue Engineering. | Adv Healthc Mater | 2019 | https://conductscience.org/library/papers/31402593 | PubMed |
| 4 | 34,093,855 | The utility of biomedical scaffolds laden with spheroids in various tissue engineering applications. | Theranostics | 2021 | https://conductscience.org/library/papers/34093855 | PubMed |
| 5 | 18,427,297 | Tissue engineering and organ structure: a vascularized approach to liver and lung. | Pediatr Res | 2008 | https://conductscience.org/library/papers/18427297 | PubMed |
| 6 | 29,199,637 | Automated 3D bioassembly of micro-tissues for biofabrication of hybrid tissue engineered constructs. | Biofabrication | 2018 | https://conductscience.org/library/papers/29199637 | PubMed |
| 7 | 29,408,559 | In vivo therapeutic applications of cell spheroids. | Biotechnol Adv | 2018 | https://conductscience.org/library/papers/29408559 | PubMed |
| 8 | 33,531,489 | 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels. | Nat Commun | 2021 | https://conductscience.org/library/papers/33531489 | PubMed |
| 9 | 33,731,359 | Three-dimensional, multifunctional neural interfaces for cortical spheroids and engineered assembloids. | Sci Adv | 2021 | https://conductscience.org/library/papers/33731359 | PubMed |
| 10 | 32,775,607 | Hydrogel-based 3D bioprinting: A comprehensive review on cell-laden hydrogels, bioink formulations, and future perspectives. | Appl Mater Today | 2020 | https://conductscience.org/library/papers/32775607 | PubMed |
| 11 | 11,282,421 | FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. | Trends Pharmacol Sci | 2001 | https://conductscience.org/library/papers/11282421 | PubMed |
| 12 | 34,672,027 | 3D Bioprinting of Cell-Laden Hydrogels for Improved Biological Functionality. | Adv Mater | 2022 | https://conductscience.org/library/papers/34672027 | PubMed |
| 13 | 29,322,028 | High-Content Monitoring of Drug Effects in a 3D Spheroid Model. | Front Oncol | 2017 | https://conductscience.org/library/papers/29322028 | PubMed |
| 14 | 28,665,236 | Formation of Adipose Stromal Vascular Fraction Cell-Laden Spheroids Using a Three-Dimensional Bioprinter and Superhydrophobic Surfaces. | Tissue Eng Part C Methods | 2017 | https://conductscience.org/library/papers/28665236 | PubMed |
| 15 | 33,667,667 | Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs. | Eur J Pharm Sci | 2021 | https://conductscience.org/library/papers/33667667 | PubMed |
| 16 | 23,469,894 | Cell-laden poly(ɛ-caprolactone)/alginate hybrid scaffolds fabricated by an aerosol cross-linking process for obtaining homogeneous cell distribution: fabrication, seeding efficiency, and cell proliferation and distribution. | Tissue Eng Part C Methods | 2013 | https://conductscience.org/library/papers/23469894 | PubMed |
| 17 | 36,925,682 | Hybrid cell constructs consisting of bioprinted cell-spheroids. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36925682 | PubMed |
| 18 | 31,577,996 | 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro. | Biofabrication | 2019 | https://conductscience.org/library/papers/31577996 | PubMed |
| 19 | 34,079,804 | Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34079804 | PubMed |
| 20 | 34,108,852 | 3D Printed Cartilage-Like Tissue Constructs with Spatially Controlled Mechanical Properties. | Adv Funct Mater | 2019 | https://conductscience.org/library/papers/34108852 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,379,698 | Engineered 3D liver-tissue model with minispheroids formed by a bioprinting process supported with in situ electrical stimulation. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38379698 | PubMed |
| 38,113,146 | Skeletal Muscle Spheroids as Building Blocks for Engineered Muscle Tissue. | ACS Biomater Sci Eng | 2024 | https://conductscience.org/library/papers/38113146 | PubMed |
| 37,818,034 | Customized Additive Manufacturing in Bone Scaffolds-The Gateway to Precise Bone Defect Treatment. | Research (Wash D C) | 2023 | https://conductscience.org/library/papers/37818034 | PubMed |
| 36,925,682 | Hybrid cell constructs consisting of bioprinted cell-spheroids. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36925682 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36925682
GET https://conductscience.org/api/papers/v1/36925682/references?page=2